ONXX Message Board - Msg: 17280740

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: (no name provided) who started this subject	4/3/2002 2:16:43 PM
From: tom pope	Read Replies (1) of 810

ONXX is moving on relatively strong volume, perhaps in response to this excerpt from the XOMA 10-k, as posted on the YAHOO board, though it does seem to be a thin reed: XOMA is working under a process development and manufacturing agreement to support the development of Onyx's ONYX-015 product, which is in Phase III testing in patients with head and neck cancer. The initial term of this agreement continues through January of 2006, with options to extend for additional periods. XOMA's spending under this agreement is billed back to Onyx on a cost-plus basis.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next